Articles producció científica> Medicina i Cirurgia

Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology

  • Dades identificatives

    Identificador: imarina:6388242
    Autors:
    Calvo, NBeltrán-Debón, RRodríguez-Gallego, EHernández-Aguilera, AGuirro, MMariné-Casadó, RMillá, LAlegret, JMSabench, Fdel Castillo, DVinaixa, MRodríguez, MACorreig, XGarcía-Alvarez, RMenendez, JACamps, JJoven, J
    Resum:
    © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. AIM: To explore the usefulness of magnetic resonance imaging (MRI) and spectroscopy (MRS) for assessment of non-alcoholic fat liver disease (NAFLD) as compared with liver histological and metabolomics findings. METHODS: Patients undergoing bariatric surgery following procedures involved in laparoscopic sleeve gastrectomy were recruited as a model of obesityinduced NAFLD in an observational, prospective, singlesite, cross-sectional study with a pre-set duration of 1 year. Relevant data were obtained prospectively and surrogates for inflammation, oxidative stress and lipid and glucose metabolism were obtained through standard laboratory measurements. To provide reliable data from MRI and MRS, novel procedures were designed to limit sampling variability and other sources of error using a 1.5T Signa HDx scanner and protocols acquired from the 3D or 2D Fat SAT FIESTA prescription manager. We used our previously described 1H NMRbased metabolomics assays. Data were obtained immediately before surgery and after a 12-mo period including histology of the liver and measurement of metabolites. Values from 1H NMR spectra obtained after surgery were omitted due to technical limitations. RESULTS: MRI data showed excellent correlation with the concentration of liver triglycerides, other hepatic lipid components and the histological assessment, which excluded the presence of non-alcoholic steatohepatitis (NASH). MRI was sufficient to follow up NAFLD in obese patients undergoing bariatric surgery and data suggest usefulness in other clinical situations. The information provided by MRS replicated that obtained by MRI using the-CH3 peak (0.9 ppm), the-CH2-peak (1.3 ppm, mostly triglyceride) and the-CH=
  • Altres:

    Autor segons l'article: Calvo, N; Beltrán-Debón, R; Rodríguez-Gallego, E; Hernández-Aguilera, A; Guirro, M; Mariné-Casadó, R; Millá, L; Alegret, JM; Sabench, F; del Castillo, D; Vinaixa, M; Rodríguez, MA; Correig, X; García-Alvarez, R; Menendez, JA; Camps, J; Joven, J
    Departament: Enginyeria Electrònica, Elèctrica i Automàtica Medicina i Cirurgia Bioquímica i Biotecnologia
    Autor/s de la URV: Alegret Colomé, Josep Maria / Beltrán Debón, Raúl Alejandro / Camps Andreu, Jorge / CAMPS RATERA, JOSEP / Correig Blanchar, Francesc Xavier / Del Castillo Déjardin, Daniel / Joven Maried, Jorge / Rodríguez Chacón, Matilde / Rodríguez Gallego, Esther / Sabench Pereferrer, Fàtima / Vinaixa Crevillent, Maria
    Paraules clau: Non-alcoholic steatohepatitis Non-alcoholic fatty liver disease Morbid obesity Mitochondrial function Metabolomics Magnetic resonance spectroscopy Magnetic resonance imaging Lipids Fatty liver disease non-alcoholic fatty liver disease morbid obesity mitochondrial function metabolomics magnetic resonance spectroscopy magnetic resonance imaging lipids fatty liver disease
    Resum: © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. AIM: To explore the usefulness of magnetic resonance imaging (MRI) and spectroscopy (MRS) for assessment of non-alcoholic fat liver disease (NAFLD) as compared with liver histological and metabolomics findings. METHODS: Patients undergoing bariatric surgery following procedures involved in laparoscopic sleeve gastrectomy were recruited as a model of obesityinduced NAFLD in an observational, prospective, singlesite, cross-sectional study with a pre-set duration of 1 year. Relevant data were obtained prospectively and surrogates for inflammation, oxidative stress and lipid and glucose metabolism were obtained through standard laboratory measurements. To provide reliable data from MRI and MRS, novel procedures were designed to limit sampling variability and other sources of error using a 1.5T Signa HDx scanner and protocols acquired from the 3D or 2D Fat SAT FIESTA prescription manager. We used our previously described 1H NMRbased metabolomics assays. Data were obtained immediately before surgery and after a 12-mo period including histology of the liver and measurement of metabolites. Values from 1H NMR spectra obtained after surgery were omitted due to technical limitations. RESULTS: MRI data showed excellent correlation with the concentration of liver triglycerides, other hepatic lipid components and the histological assessment, which excluded the presence of non-alcoholic steatohepatitis (NASH). MRI was sufficient to follow up NAFLD in obese patients undergoing bariatric surgery and data suggest usefulness in other clinical situations. The information provided by MRS replicated that obtained by MRI using the-CH3 peak (0.9 ppm), the-CH2-peak (1.3 ppm, mostly triglyceride) and the-CH=CH-peak (2.2 ppm). No patient depicted NASH. After surgery all patients significantly decreased their body weight and steatosis was virtually absent even in patients with previous severe disease. Improvement was also observed in the serum concentrations of selected variables. The most relevant findings using metabolomics indicate increased levels of triglyceride and monounsaturated fatty acids in severe steatosis but those results were accompanied by a significant depletion of diglycerides, polyunsaturated fatty acids, glucose-6-phosphate and the ATP/AMP ratio. Combined data indicated the coordinated action on mitochondrial fat oxidation and glucose transport activity and may support the consideration of NAFLD as a likely mitochondrial disease. This concept may help to explain the dissociation between excess lipid storage in adipose tissue and NAFLD and may direct the search for plasma biomarkers and novel therapeutic strategies. A limitation of our study is that data were obtained in a relatively low number of patients. CONCLUSION: MRI is sufficient to stage NAFLD in obese patients and to assess the improvement after bariatric surgery. Other data were superfluous for this purpose.
    Àrees temàtiques: Zootecnia / recursos pesqueiros Saúde coletiva Química Planejamento urbano e regional / demografia Odontología Nutrição Medicine (miscellaneous) Medicina veterinaria Medicina iii Medicina ii Medicina i Materiais Interdisciplinar Gastroenterology & hepatology Gastroenterology Farmacia Engenharias iv Engenharias ii Enfermagem Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências agrárias i Ciência de alimentos Biotecnología Biodiversidade
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 10079327
    Adreça de correu electrònic de l'autor: maria.vinaixa@urv.cat jorge.camps@urv.cat danieldel.castillo@urv.cat matilde.rodriguez@urv.cat maria.vinaixa@urv.cat jorge.joven@urv.cat josepmaria.alegret@urv.cat fatima.sabench@urv.cat esther.rodriguez@urv.cat xavier.correig@urv.cat raul.beltran@urv.cat
    Identificador de l'autor: 0000-0001-9804-0171 0000-0002-3165-3640 0000-0003-0456-3102 0000-0001-7024-7824 0000-0001-9804-0171 0000-0003-2749-4541 0000-0002-6117-5512 0000-0002-9262-8756 0000-0002-6902-3054 0000-0001-9691-1906
    Data d'alta del registre: 2024-09-07
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://www.wjgnet.com/1007-9327/full/v21/i24/7529.htm
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: World Journal Of Gastroenterology. 21 (24): 7529-7544
    Referència de l'ítem segons les normes APA: Calvo, N; Beltrán-Debón, R; Rodríguez-Gallego, E; Hernández-Aguilera, A; Guirro, M; Mariné-Casadó, R; Millá, L; Alegret, JM; Sabench, F; del Castillo, (2015). Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. World Journal Of Gastroenterology, 21(24), 7529-7544. DOI: 10.3748/wjg.v21.i24.7529
    DOI de l'article: 10.3748/wjg.v21.i24.7529
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2015
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Gastroenterology,Gastroenterology & Hepatology,Medicine (Miscellaneous)
    Non-alcoholic steatohepatitis
    Non-alcoholic fatty liver disease
    Morbid obesity
    Mitochondrial function
    Metabolomics
    Magnetic resonance spectroscopy
    Magnetic resonance imaging
    Lipids
    Fatty liver disease
    non-alcoholic fatty liver disease
    morbid obesity
    mitochondrial function
    metabolomics
    magnetic resonance spectroscopy
    magnetic resonance imaging
    lipids
    fatty liver disease
    Zootecnia / recursos pesqueiros
    Saúde coletiva
    Química
    Planejamento urbano e regional / demografia
    Odontología
    Nutrição
    Medicine (miscellaneous)
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Materiais
    Interdisciplinar
    Gastroenterology & hepatology
    Gastroenterology
    Farmacia
    Engenharias iv
    Engenharias ii
    Enfermagem
    Educação física
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciências agrárias i
    Ciência de alimentos
    Biotecnología
    Biodiversidade
  • Documents:

  • Cerca a google

    Search to google scholar